NEWTYN MANAGEMENT, LLC – Theravance Biopharma, Inc. Transaction History
NEWTYN MANAGEMENT, LLC portfolio value:
$25.30M
portfolio value
NEWTYN MANAGEMENT, LLC quarter portfolio value change:
+11.92%
quarter
Theravance Biopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +22.48% | 458.03K shares | 6.84M | $10.14 | 2.49M |
| Q2 2022 | share | Increase | +48.21% | 662.82K shares | 5.31M | $9.06 | 2.03M |
| Q1 2022 | share | Increase | +37.50% | 375K shares | 2.09M | $9.56 | 1.37M |
| Q4 2021 | share | Increase | +920.88% | 902.04K shares | 10.32M | $10.98 | 1M |
| Q3 2021 | share | Increase | 0.00% | 97.95K shares | 725K | $7.4 | 97.95K |
| Q1 2020 | share | Decrease | -100.00% | -173.3K shares | -4.48M | $23.11 | 0 |
| Q4 2019 | share | Increase | +172.14% | 109.61K shares | 3.24M | $25.89 | 173.3K |
| Q3 2019 | share | Increase | 0.00% | 63.68K shares | 1.24M | $19.48 | 63.68K |